Omeros | OMER - Actif À Court Terme





Actif À Court Terme Changement Date
Adma Biologics USD 466.51M 63.86M 2025-12
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Cytokinetics USD 839.46M 77.51M 2026-03
Gilead Sciences USD 19.89B 1.05B 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Immunic USD 22.87M 16.4M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 514.96M 33.01M 2026-03
Pfizer USD 42.82B 76M 2026-03
Rockwell Medical USD 31.61M 1.42M 2025-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xoma USD 110.71M 5.78M 2025-09